Clinical outcomes | All infants (n=37) |
IRDS | 8 (21.6) |
Surfactant therapy | 7 (18.9) |
Respiratory support <72 hours | 28 (75.7) |
Nasal cannula | 0 |
CPAP/High flow | 23 (62.2) |
Invasive ventilation | 5 (13.5) |
Inotropes <72 hours | 2 (5.4) |
PDA diagnosed | 7 (18.9) |
Treated | 5 (13.5) |
NEC ≥stage 2 | 3 (8.1) |
Late onset infection | 11 (29.7) |
Hyperbilirubinaemia | |
Phototherapy | 35 (94.6) |
Exchange transfusion | 0 |
Erythrocyte transfusion | 7 (18.9) |
Polycythaemia | 3 (8.1) |
IVH | 5 (13.5) |
Grade 1 | 2 (5.4) |
Grade 2 | 1 (2.7) |
Grade 3 | 2 (5.4) |
Venous infarction | 1 (2.7) |
Ventricular dilatation | 1 (2.7) |
ROP | 4 (10.8) |
Grades 1–2 | 4 (10.8) |
Grades 3–4 | 0 |
BPD | 3 (8.1) |
Mild | 0 |
Moderate | 0 |
Severe | 3 (8.1) |
Data are presented as n (%).
BPD, bronchopulmonary dysplasia; CPAP, continuous positive airway pressure; IRDS, infant respiratory distress syndrome; IVH, intraventricular haemorrhage; NEC, necrotising enterocolitis; PDA, persistent ductus arteriosus; ROP, retinopathy of prematurity.